MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL)

Q: What does CUSIP 558868105 represent in this 13F holders report?

CUSIP 558868105 is the security identifier for MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share in Q1 2020?

106 institutional investors reported MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share for Q1 2020. Use the holders table for investor-level position and value details.

CUSIP: 558868105

Q1 2020 13F Holders as of 31 Mar 2020

Security type / class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 22,822,754
Total 13F shares: 11,048,035
Share change: +610,369
Total reported value: $737,557,931
Put/Call ratio: 441%
Reported price per share: $66.76
Number of holders: 106
Value change: +$26,608,051
Number of buys: 58
Number of sells: 52

Security key

558868105

Report period

Q1 2020

Institutions

106

Top holders

MDGL full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2020 Previous quarter: Q4 2019 MADRIGAL PHARMACEUTICALS, INC. SEC filings MADRIGAL PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 558868105

Newer quarter: Q2 2020 Previous quarter: Q4 2019

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

Capital Research Global I...

13D/G signal

—

Evidence rows

Latest as of

31 Dec 2019

13F Lead comparable stake: 7.4% Showing 1-6 of 15 holder rows.

Rank 1 holder

Capital Research Global Investors

13F

Ownership: 7.4%
Position: $154.62M

13F

Rank 2 holder

BAKER BROS. ADVISORS LP

13F

Ownership: 5.1%
Position: $106.53M

13F

Rank 3 holder

HealthCor Management, L.P.

13F

Ownership: 4.8%
Position: $99.16M

13F

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Capital Research Global Investors	13F Company 13F	7.4%	$154,625,000 1,697,119 shares	—	31 Dec 2019
BAKER BROS. ADVISORS LP	13F Company 13F	5.1%	$106,533,000 1,169,278 shares	—	31 Dec 2019
HealthCor Management, L.P.	13F Company 13F	4.8%	$99,156,000 1,088,310 shares	—	31 Dec 2019
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	4.2%	$87,205,000 957,146 shares	—	31 Dec 2019
VANGUARD GROUP INC	13F Company 13F	3.4%	$71,561,000 785,441 shares	—	31 Dec 2019
BlackRock Finance, Inc.	13F Company 13F	2.5%	$52,824,000 579,780 shares	—	31 Dec 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

106

11,048,035

Rows available

106

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

119

Q1 2020 holders

106

Holder diff

-13

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 value	Q1 2020 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend